These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7559147)

  • 1. Enhanced pharmacological testing in patients with erectile dysfunction.
    Vruggink PA; Diemont WL; Debruyne FM; Meuleman EJ
    J Androl; 1995; 16(2):163-8. PubMed ID: 7559147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
    de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracavernous injection of vasoactive substances in the treatment of erectile dysfunction].
    Wehnert J; Kramer J; Weller J; Leike S
    Z Urol Nephrol; 1988 Feb; 81(2):73-8. PubMed ID: 3369250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results and acceptance of corpus cavernosum autoinjection therapy in organic erectile dysfunction].
    Steffens J; Postma HJ; Steffens L
    Urologe A; 1988 Jan; 27(1):14-6. PubMed ID: 3363768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness and safety of cavernous body auto-injection therapy with papaverine/phentolamine. Study group].
    Thon WF; Hartmann U
    Urologe A; 1993 Nov; 32(6):466-9. PubMed ID: 8284856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction of an erection using papaverine].
    Terek A; Sekei J; Getz F
    Urol Nefrol (Mosk); 1989; (3):69-71. PubMed ID: 2773185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term experiences with autoinjection therapy of papaverine in erectile dysfunction].
    Jantos C; Krause W; Kauss E; Weidner W
    Urologe A; 1988 Jan; 27(1):18-21. PubMed ID: 3363769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary results of the treatment of erectile impotence by intracavernous self administration of vasoactive substances].
    Stief CG; Bähren W; Beckert R; Altwein JE
    J Urol (Paris); 1986; 92(6):349-51. PubMed ID: 3794379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences with intracavernous auto-injection for the treatment of erection disorders].
    van Deventer CP; Meuleman EJ; Bierkens PB; Sabbe BG; Smals AG
    Ned Tijdschr Geneeskd; 1993 Feb; 137(8):408-12. PubMed ID: 8446199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Our experience with pharmacological erection treatment of erectile dysfunction.
    Hattat H; Ozkara H; Akkus E; Alici B
    J Androl; 1994; 15 Suppl():47S-49S. PubMed ID: 7721677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual erotic and vibrotactile stimulation and intracavernous injection in screening men with erectile dysfunction: a 3 year experience with 406 cases.
    Incrocci L; Hop WC; Slob AK
    Int J Impot Res; 1996 Dec; 8(4):227-32. PubMed ID: 8981172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracavernous injection therapy in recovery of spontaneous erection (not for self-injection)--its mechanism and indications.
    Imagawa A; Kawanishi Y; Tamura M
    Hinyokika Kiyo; 1989 Jul; 35(7):1145-8. PubMed ID: 2801406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
    Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM
    Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2 years' experiences with cavernosal autoinjection therapy].
    Stief CG; Thon WF; Scherb W; Gall H; Bähren W
    Urologe A; 1987 Sep; 26(5):294-6. PubMed ID: 2446413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of sildenafil as mode of stimulation in pharmaco-penile duplex ultrasonography.
    Speel TG; Bleumer I; Diemont WL; van der Maas MC; Wijkstra H; Meuleman EJ
    Int J Impot Res; 2001 Aug; 13(4):189-91. PubMed ID: 11494073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction.
    Bechara A; Casabé A; Chéliz G; Romano S; Rey H; Fredotovich N
    J Urol; 1997 Jun; 157(6):2132-4. PubMed ID: 9146599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.